佛 “Astra is allowed until age 74”… Korea may also attract vaccinations for the elderly

AstraZeneca Vaccine Fit Caregiver On the 2nd, a nursing care worker is receiving the AstraZeneca Corona 19 vaccine at the elderly care center in Yangcheon-gu, Seoul. As countries around the world have allowed the use of the AstraZeneca vaccine for the elderly, the Korean quarantine authorities will also reconsider whether the vaccine is vaccinated for the elderly. Reporter Jang Seung-yoon [email protected]-Additional research data have emerged demonstrating the effectiveness of the UK AstraZeneca vaccine in vaccinating the elderly. France allowed vaccinations for people over 65 years of age. In Korea, there is a high possibility that the timing of reconsideration of vaccinations for the elderly, which has been delayed since the end of March, will be accelerated.

French Minister of Health Olivier Berand said on the 1st (local time), “French citizens aged 50 and over with complications, including those between 65 and 74, will be able to get the AstraZeneca vaccine at hospitals and pharmacies within a few days.” Initially, France recommended the AstraZeneca vaccination age to be’under 65′ as in Korea. The French government, which restricted vaccination for the elderly due to lack of clinical information, changed its policy.

In the UK, where the AstraZeneca vaccine is being vaccinated against the elderly, studies have shown that it has a certain effect on the elderly as well. The UK’s England Public Health Agency (PHE) announced on the same day that “a survey of the elderly aged 80 and over who received a single dose of the AstraZeneca and Pfizer vaccines from January showed that the possibility of hospitalization after 3 or 4 weeks of vaccination was reduced by 80%.” In addition, Pfizer vaccine showed 57-61% of preventive effects and 60-73% of AstraZeneca vaccine for those over 70 years old. British Health Minister Matt Hancock said, “The AstraZeneca vaccine was slightly more effective than Pfizer’s at a single dose,” said British Health Minister Matt Hancock.

The Korean quarantine authorities are also paying attention to the research results. Chung Kyung-sil, head of the vaccination management team of the Corona 19 Vaccination Response Promotion Team, at a briefing on the day, “I think that if sufficient data is accumulated by comprehensively judging the results of various papers and clinical trials in progress in each country, (elderly vaccination) can be judged anytime. Said. It changed the existing policy of reviewing the US phase 3 clinical data of the AstraZeneca vaccine released at the end of March. Experts also point out that there is a need to accelerate AstraZeneca vaccination for the elderly. Eun-mi Chun, a professor of respiratory medicine at Ewha Womans University Mokdong Hospital, said, “The results of a British study in which the AstraZeneca vaccine was actually applied to the elderly are encouraging.” However, there are concerns that the lack of vaccine supply and demand could be an obstacle to realizing this. The AstraZeneca vaccine introduced so far is for 785,000 people. Of these, 31,133 people were allocated to workers under the age of 65 among workers in nursing hospitals and facilities, and vaccinations began on the 26th of last month. During this month, 78513 Corona 19 first responders and 3,540,039 workers in high-risk medical institutions will also receive the AstraZeneca vaccine. Currently, the AstraZeneca vaccine introduced in Korea is already targeted for vaccination. Kim Woo-joo, a professor of infectious medicine at Korea University’s Guro Hospital, said, “Even if the elderly people decide to inoculate the AstraZeneca vaccine, there is no vaccine,” he said.

Reporter Jiwoon Lee [email protected] / Paris = Correspondent Yoonjong Kim